TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025
1. TNFA presented a novel treatment for sarcopenia at a significant medical conference. 2. The breakthrough could enhance TNFA's profile and valuation in the biopharma sector.